We aimed to identify the white matter (WM) and grey matter (GM) abnormalities in multiple system atrophy (MSA) and assess the utility of longitudinal structural and diffusion changes as surrogate markers for tracking disease progression in MSA.
No takes yet. Share an insight, caveat, or question.
Raghavan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: